科研之友
微信
新浪微博
Facebook
分享链接
摘要
introduction and objective: multiple myeloma is an incurable malignancy characterized by the proliferation of a single clone of plasma cells in bone marrow. the aim of this study was to evaluate the frequency and prognostic value of the expression of aberrant phenotypes in patients with multiple myeloma by multiparametric flow cytometry. methods: the study was carried out at department of hematology and hemotherapy of federal university of sˋo paulo and 30 patients with mm were analyzed prospectively. in an attempt to identify myeloma cells by flow cytometry (facscalibur, bd), specific monoclonal antibodies anti-cd138, anti-cd38 and anti-cd45 were used for the selection of plasma cells. the control group comprised four healthy bone marrow donors. results: all myeloma plasma cells expressed at least one aberrant phenotype and cd56+++, cd117++, cd33++, cd13++ and cd28++ markers were more frequently observed in 88% of patients. lymphoid markers were found in cases with a higher number of aberrant phenotypes. discussion: cd56+++ and cd28++ antigens showed high levels of 汕2-microglobulin, which are associated with more aggressive stages of the disease and larger tumor mass. the absence of adhesion molecule cd56 was associated with high levels of 汕2m and calcium ion, showing that this finding may have prognostic value. conclusion: from this study it was concluded that the aberrant phenotypes are present in most cases of mm, and immunophenotyping by multiparametric flow cytometry is a useful tool to distinguish normal plasma cells from myeloma plasma cells.
- 出版日期2010
